{
    "organizations": [],
    "uuid": "af5d8ce015e18da42dee09fe08b3306f3f98e092",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-north-china-pharmaceutical-gets-ap/brief-north-china-pharmaceutical-gets-approval-to-issue-2-0-billion-yuan-commercial-paper-idUSH9N1RO028",
    "ord_in_thread": 0,
    "title": "BRIEF-North China Pharmaceutical Gets Approval To Issue 2.0 Billion Yuan Commercial Paper",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 16 (Reuters) - North China Pharmaceutical Co Ltd :\n* SAYS IT GETS APPROVAL TO ISSUE 2.0 BILLION YUAN ($318.51 million) COMMERCIAL PAPER Source text in Chinese: bit.ly/2qzhBC4 Further company coverage: ($1 = 6.2792 Chinese yuan renminbi) (Reporting by Hong Kong newsroom)\n ",
    "published": "2018-04-16T21:11:00.000+03:00",
    "crawled": "2018-04-17T12:26:29.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "north",
        "china",
        "pharmaceutical",
        "co",
        "ltd",
        "say",
        "get",
        "approval",
        "issue",
        "billion",
        "yuan",
        "million",
        "commercial",
        "paper",
        "source",
        "text",
        "chinese",
        "company",
        "coverage",
        "chinese",
        "yuan",
        "renminbi",
        "reporting",
        "hong",
        "kong",
        "newsroom"
    ]
}